Share on StockTwits

Bristol-Myers Squibb (NYSE:BMY) declared a quarterly dividend on Tuesday, June 17th, Stock Ratings Network.com reports. Shareholders of record on Thursday, July 3rd will be given a dividend of 0.36 per share on Friday, August 1st. This represents a $1.44 dividend on an annualized basis and a yield of 3.03%.

A number of research firms have recently commented on BMY. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Bristol-Myers Squibb in a research note on Thursday, June 5th. They now have a $46.59 price target on the stock, down previously from $59.00. On a related note, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Bristol-Myers Squibb in a research note on Thursday, May 15th. They now have a $60.00 price target on the stock. Finally, analysts at Citigroup Inc. cut their price target on shares of Bristol-Myers Squibb from $60.00 to $55.00 in a research note on Thursday, May 15th. They now have a “market perform” rating on the stock. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $55.12.

Bristol-Myers Squibb (NYSE:BMY) traded up 0.40% during mid-day trading on Tuesday, hitting $47.46. 7,927,582 shares of the company’s stock traded hands. Bristol-Myers Squibb has a 52-week low of $41.11 and a 52-week high of $57.49. The stock has a 50-day moving average of $49.13 and a 200-day moving average of $51.53. The company has a market cap of $78.650 billion and a P/E ratio of 27.32.

Bristol-Myers Squibb (NYSE:BMY) last announced its earnings results on Tuesday, April 29th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.43 by $0.03. The company had revenue of $3.81 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was down .5% on a year-over-year basis. On average, analysts predict that Bristol-Myers Squibb will post $1.78 earnings per share for the current fiscal year.

Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.